A record of what ETMarkets Analysis said publicly, with the source. Not advice.
“Short-term traders should consider buying Fortis Healthcare, either immediately or on dips, targeting ₹1,050 within the next 3-4 weeks. The stock shows positive momentum, trading above key moving averages, with a recommended stop-loss at ₹930, as the rally may not be over despite hitting a fresh record high in September.”
ETMarkets Analysis’s track record (trackable calls only): 193 graded calls · 95% CI 23–35%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
No entry price is stated, so the call starts at the first close after it was published.
Target ₹1,050, stop ₹930, as stated.
Window: 28 days, the time frame the call states ("3-4 weeks").
The target ₹1,050 was reached on a close before the stop ₹930. Hit.
The grader’s working: R4 TARGET_CALL: entered ₹966.65 on 2025-09-16 (next trading session's close); target ₹1050 reached at close ₹1053.9 on 2025-10-06. Window 28 days — rule H1: the quote states "3-4 weeks".
How it played out
How this is worked out- Target or stop first
- The target was reached on a close before the stop was.
- Time to target
- The target was reached on a close 13 trading sessions (20 calendar days) after the entry.
- Worst close against it
- The closing price went as far as 3.51% against the call before the target was reached, measured from the entry price. Closing prices only; an intraday dip is never counted.
From the entry the grade used, on closing prices. This is a record of one past call and is not advice.